Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels

Neil H. Riordan, Maria Luisa Hincapié, Isabela Morales, Giselle Fernandez, Nicole Allen, Cindy Leu, Marialaura Madrigal, Jorge Paz Rodriguez, Nelson Navarro First published: 11 June 2019 https://doi.org/10.1002/sctm.19-0010 Data Availability Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request. Abstract Individuals with autism spectrum disorder (ASD) [...]

The Effect of Umbilical Cord-derived Mesenchymal Stem Cell Transplantation in a Patient with Cerebral Palsy: A Case Report.

Okur SÇ1, Erdoğan S2, Demir CS3, Günel G3, Karaöz E2,3,4. Author Information: 1 Department of Physical Therapy and Rehab, Health Science University, Bakirköy Dr Sadi Konuk Training and Research Hospital, İstanbul, Turkey. 2 Department of Histology and Embryology, İstinye University, Faculty of Medicine, İstanbul, Turkey. 3 Center for Stem Cell and Tissue Engineering Research and Practice, İstinye University, İstanbul, [...]

VIDEO: Neil Riordan, PA, PhD discusses Stem Cells: Their Role in Aging and in the Treatment of Chronic Diseases

At our May 4th 2019 event in Southlake, Texas, Dr. Riordan discusses stem cell therapy at the Stem Cell Institute in Panama City, Panama. He mentions the two main types of adult stem cells but his talk focuses on mesenchymal stem cells including their sources and functions. Then he goes on to [...]

Neil Riordan, PA, PhD Presents at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th

Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th. Neil Riordan, PA, PhD SALT LAKE CITY (PRWEB) MARCH 01, 2019Neil Riordan, [...]

Multiple Sclerosis News Today Covers Stem Cell Institute Clinical Trial for MS

Stem cells being prepared for treatment. Multiple Sclerosis News Today has published an article entitled "Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows". This article can be read in its entirely at MultipleSclerosisNewsToday.com.The name of the study, which is published in the Journal of Translational Medicine, is “Clinical [...]

Podcast: Listen to Dr. Mike Hutchinson, DVM interview with Dr. Riordan about stem cell therapy

About This Episode Delve deeper into the stem cell world with pioneer and expert Dr. Neil Riordan. Co-founder/chief science officer of the Riordan-McKenna Institute, founder/chairman/chief science officer of the Stem Cell Institute and author of Stem Cell Therapy: A Rising Tide, he’s here to discuss ongoing stem cell studies with Duchenne Muscular Dystrophy, spinal cord [...]

Stem cell pioneer sets sights on Japan – Japan Times features Neil Riordan, PhD of Medistem Panama

"We enjoy the advantage of having a large amount of clinical data on 2,000 patients. So we analyzed who received which cells and which cells worked best in different conditions. This allowed us to create our selection process through molecular profiling,” explained Medistem (Panama) Founder and CEO Dr. Neil Riordan. Operating what is arguably the [...]

US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US

(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application [...]

New article concludes US FDA restrictions hampering stem cell therapy progress

An article published this month in Thieme Journal of Knee Surgery entitled, "The Use of Biologic Agents in Athletes with Knee Injuries" concluded that "Biologic agents... are becoming the mainstay of nonoperative therapy in the high-demand athletic population." but "...Unfortunately, strict regulations by the FDA continue to restrict their application in clinical practice." The good [...]

First Duchenne’s Muscular Dystrophy Patient To Receive Umbilical Cord Stem Cell Therapy In US Turns 30

The first patient with Duchenne Muscular Dystrophy to be granted FDA approval for allogeneic adult stem cell therapy in the United States turned 30 this year, well surpassing his original life expectancy and paving the way for future patients, according to non-profit organization Coming Together For A Cure. Ryan Benton WICHITA, KANSAS (PRWEB) MAY [...]